journal article·2017-11-13Open access

Neuroprotective effects and UPLC-Q-TOF/MS-based active components identification of external applied a novel Wen-Luo-Tong microemulsion

Hong-Mei Lin, Long-Fei Lin, Zhen-Zhen Xia, Yong Mao, Jia Liu, Ling-Yan Xu, Qing Wu

Abstract

Chemotherapy induced neuropathy causes excruciating pain to cancer patients. Wen-Luo-Tong (WLT), a traditional Chinese medicinal compound, has been used to alleviate anti-cancer drug such as oxaliplatin-induced neuropathic pain for many years. However, the current route of administration of WLT is inconvenient and the active ingredients and mechanism of action of WLT are still unclear. To address these issues, we developed a novel formulation of WLT (W/O microemulsion) for the ease of application. New ultra-performance liquid chromatography-quadrupole time-of-flight mass spectrometry (UPLC-Q-TOF/MS) methods were employed for analysis of the ingredients. We identified seven ingredients that penetrated through the skin into the Franz cell receptor solution and four of those ingredients were retained in skin tissue when WLT microemulsion was applied. We tested the microemulsion formulation on an oxaliplatin-induced neuropathy rat model and showed that this formulation significantly decreased oxaliplatin-induced mechanical hyperalgesia responses. Schwann cells (SCs) viability experiment in vitro was studied to test the protective effect of the identified seven ingredients. The result showed that Hydroxysafflor Yellow A, icariin, epimedin B and 4-dihydroxybenzoic acid significantly increased the viability of SCs after injured by Oxaliplatin. Our report presents the first novel formulation of WLT with neuroprotective effect and ease of use, which has potential for clinical applications.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Cancer Treatment and Pharmacology · Plant-based Medicinal Research · Traditional Chinese Medicine Analysis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of TCM Pharmaceutics, School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China;

Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China;

New Jersey Center for Biomaterials, Rutgers-The State University of New Jersey, Piscataway, NJ, USA

References (36)

Show source-provided references
1. 10.1016/j.critrevonc.2011.04.01210.1016/j.critrevonc.2011.04.012 ↗
2. 10.1016/j.neuropharm.2015.05.02110.1016/j.neuropharm.2015.05.021 ↗
3. 10.1080/0284186070135505510.1080/02841860701355055 ↗
4. 10.1016/j.neuroscience.2011.12.02310.1016/j.neuroscience.2011.12.023 ↗
5. 10.1016/j.ejpain.2010.08.00610.1016/j.ejpain.2010.08.006 ↗
6. 10.1016/j.molmed.2016.03.00810.1016/j.molmed.2016.03.008 ↗
7. 10.1016/j.jns.2015.03.02910.1016/j.jns.2015.03.029 ↗
8. 10.1016/j.clcc.2013.11.00410.1016/j.clcc.2013.11.004 ↗
9. 10.1016/j.critrevonc.2015.11.01410.1016/j.critrevonc.2015.11.014 ↗
10. 10.3816/CCC.2002.n.01110.3816/CCC.2002.n.011 ↗
11. 10.1016/j.critrevonc.2013.08.00910.1016/j.critrevonc.2013.08.009 ↗
12. 10.1016/j.ejca.2012.03.01810.1016/j.ejca.2012.03.018 ↗
13. Qin Y. · 2010
14. Wei M. · 2014
15. Yuan Y. · 2015
16. Lou Y · Chin J Tradit Chin Med Pharm · 2014 · 29 · 2682
17. Deng B · J Evid Based Complementary Altern Med · 2016 · 2016 · 362948910.1155/2016/3629489 ↗
18. Zhu T · J Tradi Chin Orthopedic Traumatol. · 1993 · 5 · 3
19. Qin Z · 2012
20. Zhang Y · Stroke Nerv Dis. · 2011 · 18 · 357
21. Li D · J Nanjing Univ TCM · 2014 · 30 · 186
22. 10.1631/jzus.B130023010.1631/jzus.B1300230 ↗
23. 10.1016/j.pain.2010.10.01510.1016/j.pain.2010.10.015 ↗
24. Li X · Zhong Yao Cai · 2012 · 35 · 1616
25. Gan J · Modern Med Clin · 2014 · 29 · 349
26. 10.1016/j.ejpb.2014.06.00710.1016/j.ejpb.2014.06.007 ↗
27. 10.1016/j.jchromb.2016.03.01210.1016/j.jchromb.2016.03.012 ↗
28. 10.1016/j.brainres.2010.12.05310.1016/j.brainres.2010.12.053 ↗
29. Peng Q. · China Pharm · 2011 · 22 · 2139
30. Xiu X · Zhong Yao Cai · 2011 · 34 · 567
31. 10.1016/j.neuro.2006.04.01010.1016/j.neuro.2006.04.010 ↗
32. 10.1016/j.brainresbull.2004.02.00510.1016/j.brainresbull.2004.02.005 ↗
33. 10.1016/j.neulet.2016.04.05710.1016/j.neulet.2016.04.057 ↗
34. 10.1016/j.neuroscience.2016.05.01910.1016/j.neuroscience.2016.05.019 ↗
35. 10.1016/j.brainres.2015.09.02510.1016/j.brainres.2015.09.025 ↗
36. 10.1016/j.biomaterials.2016.02.01010.1016/j.biomaterials.2016.02.010 ↗